Recombinant zoster vaccine (Shingrix(®)): a new option for the prevention of herpes zoster and postherpetic neuralgia

Postherpetic neuralgia (PHN) is a challenging condition for pain management specialists. The prevention of herpes zoster (HZ) and subsequent PHN in individuals aged 50 years and older, via the development of new vaccines, is an ongoing research project. The live zoster vaccine (LZV, Zostavax(®)) was...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Grisuna, Song, Sejin, Choi, Eunjoo, Lee, Pyung-Bok, Nahm, Francis Sahngun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pain Society 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336348/
https://www.ncbi.nlm.nih.gov/pubmed/32606264
http://dx.doi.org/10.3344/kjp.2020.33.3.201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336348/
https://www.ncbi.nlm.nih.gov/pubmed/32606264
http://dx.doi.org/10.3344/kjp.2020.33.3.201

Ejemplares similares